Glipizide Active Pharmaceutical Ingredient from China

Glipizide is an aromatic imine-function compound used as the active ingredient in oral antidiabetic medications for type 2 diabetes treatment. It falls under HTS 2925.29.20.00 as a drug classified among aromatic imines and their derivatives. This bulk API is imported for pharmaceutical formulation into tablets.

Duty Rate — China → United States

31.5%

Rate breakdown

9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

Obtain FDA Drug Master File (DMF) and ensure Certificate of Analysis meets USP standards

Provide detailed impurity profile and stability data required for API drug imports

Verify aromatic imine structure classification to avoid reclassification under 2933 headings